Breast/lungcancer
21 – 30 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Real-World Treatment Patterns and Survival Outcomes for Patients with Non-Metastatic Non-Small-Cell Lung Cancer in Sweden : A Nationwide Registry Analysis from the I-O Optimise Initiative
(
- Contribution to journal › Article
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
-
Mark
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
(
- Contribution to journal › Article
-
Mark
Genomic alterations associated with resistance and circulating tumor DNA dynamics for early detection of progression on CDK4/6 inhibitor in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Tumor purity estimated from bulk DNA methylation can be used for adjusting beta values of individual samples to better reflect tumor biology
(
- Contribution to journal › Article
-
Mark
Protumoral lipid droplet-loaded macrophages are enriched in human glioblastoma and can be therapeutically targeted
(
- Contribution to journal › Article
-
Mark
Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants
(
- Contribution to journal › Article
-
Mark
The analytical and clinical validity of AI algorithms to score TILs in TNBC : can we use different machine learning models interchangeably?
(
- Contribution to journal › Article
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
2024) European Association for Cancer Research(
- Contribution to conference › Poster
-
Mark
Kataegis in clinical and molecular subgroups of primary breast cancer
(
- Contribution to journal › Article